A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Kidney International Année : 2022

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Résumé

Research Letter

Dates et versions

pasteur-03696743 , version 1 (16-06-2022)

Identifiants

Citer

Ilies Benotmane, Timothée Bruel, Delphine Planas, Samira Fafi-Kremer, Olivier Schwartz, et al.. A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients. Kidney International, 2022, 101 (5), pp.1073-1076. ⟨10.1016/j.kint.2022.02.011⟩. ⟨pasteur-03696743⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More